SCHEMBL7731085

SCHEMBL7731085

CCCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(OC(=O)C(F)(F)F)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 9/20 0.42
HTR2A P28223 8/20 0.40
HTR2C P28335 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
KCNH2 Q12809 2/20 0.40
HTR2B P41595 1/20 0.40
EPHX1 P07099 1/20 0.39
UBE2M P61081 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
HRH3 Q9Y5N1 2/20 0.39
ABCB11 O95342 1/20 0.39
ADRB2 P07550 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD1 P21728 1/20 0.39
TBXA2R P21731 1/20 0.39
SLC6A2 P23975 1/20 0.39
GPR183 P32249 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7723375 0.87 CCR5 (0.43) CCR5HTR2AEPHX1HRH3
SCHEMBL7732604 0.87 CCR5 (0.51) CCR5HTR2AHTR2CCYP1A2CYP2C19
SCHEMBL7732703 0.84 CCR5 (0.53) CCR5
Trifluoroacetic Acid SCHEMBL7731077 0.81 HTR2A (0.44) CCR5HTR2AKCNH2EPHX1DCUN1D1
SCHEMBL7733272 0.76 HTR2A (0.47) CCR5HTR2AHTR2CCYP1A2CYP2C19
SCHEMBL8095172 0.71 CCR5 (0.42) CCR5
Hydrochloric Acid SCHEMBL7668700 0.70 HTR2A (0.48) CCR5HTR2AKCNH2EPHX1SLC6A2
SCHEMBL7773992 0.69 ALDH1A1 (0.51) EPHX1
Trifluoroacetic Acid SCHEMBL7732600 0.68 SLC6A4 (0.48) CCR5HTR2AKCNH2DCUN1D1SLC6A2
Trifluoroacetic Acid SCHEMBL7723374 0.67 EPHX1 (0.43) CCR5HTR2AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399619-B1 PREVENTION AND TREATMENT OF AIDS AND VIRAL INFECTION BY HIV MERCK & CO., INC. 2002-06-04 US disclosed